Therapy News and Research

RSS

FDA revokes EUA for monoclonal antibody therapy bamlanivimab to treat patients with COVID-19

Today, the U.S. Food and Drug Administration revoked the emergency use authorization (EUA) that allowed for the investigational monoclonal antibody therapy bamlanivimab, when administered alone, to be used for the treatment of mild-to-moderate COVID-19 in adults and certain pediatric patients.

17 Apr 2021

Studies suggest mRNA COVID-19 vaccine may have reduced efficacy in patients with blood cancer

Two new studies published in Blood suggest that the mRNA COVID-19 vaccine may have reduced efficacy in individuals with chronic lymphocytic leukemia (CLL) and multiple myeloma, two types of blood cancer.

17 Apr 2021

Three teams selected to receive the first awards from Dartmouth Innovations Accelerator for Cancer

Three teams of Dartmouth researchers have been selected to receive the first awards from the Dartmouth Innovations Accelerator for Cancer.

17 Apr 2021

Novel PET tracer is safe and can clearly identify early stages of rheumatoid arthritis

New research shows that a novel positron emission tomography (PET) tracer that targets inflammation is safe and can clearly identify early stages of rheumatoid arthritis.

17 Apr 2021

FDA approves immunotherapy for first-line treatment of advanced gastric cancer

Today, the U.S. Food and Drug Administration approved Opdivo (nivolumab), in combination with certain types of chemotherapy, for the initial treatment of patients with advanced or metastatic gastric cancer, gastroesophageal junction cancer and esophageal adenocarcinoma.

16 Apr 2021

New and more effective treatment for Pompe disease

Rare diseases are sometimes the most difficult to treat because of a lack of research and fewer participants to study.

16 Apr 2021

Repurposing an existing, cheap drug into long-acting injectable therapy to treat Covid-19

Researchers from the University of Liverpool have shown the potential of repurposing an existing and cheap drug into a long-acting injectable therapy that could be used to treat Covid-19.

16 Apr 2021

Study reveals new genes that program stem cells to make dendritic cells

Using a new single-cell technique, WEHI researchers have uncovered a way to understand the programming behind how stem cells make particular cell types.

16 Apr 2021

Trial results show leishmaniasis vaccine is safe and induces immune responses in patients

The results of the first clinical trial of a new vaccine for a neglected tropical disease have demonstrated that it is safe and induces immune responses in patients with the infection.

15 Apr 2021

New recipients for the 2021 NCCN Foundation Young Investigator Awards announced

The National Comprehensive Cancer Network and the NCCN Foundation today announced six new recipients for the 2021 NCCN Foundation Young Investigator Awards Program.

15 Apr 2021

CHOP researchers identify key target responsible for treatment failure in patients with hemophilia A

Researchers at Children's Hospital of Philadelphia have identified a key target that may be responsible for treatment failure in about 30% of patients with hemophilia A.

15 Apr 2021

Researchers develop “Nano-Glue” with therapeutic potential against SARS-CoV-2

In a recent study, researchers target the electropositive receptor-binding domain (RBD) on the SARS-CoV-2 spike protein with the abundant β-sheet structure as a novel COVID-19 therapeutic drug design.

15 Apr 2021

Study observes neurological and psychiatric outcomes in recovered COVID-19 patients six months post-infection

A new study by researchers at Oxford University examines neurological and psychiatric outcomes in recovered COVID-19 patients six months post-infection.

15 Apr 2021

Abbott’s XIENCE™ Stent Receives European Approval for One-Month Dual Anti-Platelet Therapy (DAPT) for High Bleeding Risk Patients

Abbott today announced its XIENCE stent has received CE Mark in Europe for shorter duration of dual antiplatelet therapy (DAPT).

15 Apr 2021

Airports step up mental health assistance as passenger anxiety soars

Robin Hancock gently worked her steel tongue drum with a pair of mallets, producing a set of soothing, mystical tones. They blended with the soft sound of chirping birds and bubbling creeks pouring from a Bluetooth speaker. Her warm voice invited the two visitors in the dimly lit room to slip into a nature setting of their choosing.

15 Apr 2021

Study analyzes trends in age at natural menopause and reproductive life span among US women

As females age, their bodies typically undergo two significant changes that generally occur during adolescence and middle age.

15 Apr 2021

Study may lead to new therapies for patients suffering from Duchenne muscular dystrophy

A new study, led by the University of California, Irvine (UCI), reveals how chronic inflammation promotes muscle fibrosis, which could inform the development of new therapies for patients suffering from Duchenne muscular dystrophy (DMD), a fatal muscle disease.

15 Apr 2021

Therapy News and Research

FDA revokes EUA for monoclonal antibody therapy bamlanivimab to treat patients with COVID-19

Studies suggest mRNA COVID-19 vaccine may have reduced efficacy in patients with blood cancer

Three teams selected to receive the first awards from Dartmouth Innovations Accelerator for Cancer

Novel PET tracer is safe and can clearly identify early stages of rheumatoid arthritis

FDA approves immunotherapy for first-line treatment of advanced gastric cancer

New and more effective treatment for Pompe disease

Repurposing an existing, cheap drug into long-acting injectable therapy to treat Covid-19

Study reveals new genes that program stem cells to make dendritic cells

Trial results show leishmaniasis vaccine is safe and induces immune responses in patients

New recipients for the 2021 NCCN Foundation Young Investigator Awards announced

CHOP researchers identify key target responsible for treatment failure in patients with hemophilia A

Researchers develop “Nano-Glue” with therapeutic potential against SARS-CoV-2

Study observes neurological and psychiatric outcomes in recovered COVID-19 patients six months post-infection

Abbott’s XIENCE™ Stent Receives European Approval for One-Month Dual Anti-Platelet Therapy (DAPT) for High Bleeding Risk Patients

Airports step up mental health assistance as passenger anxiety soars

Study analyzes trends in age at natural menopause and reproductive life span among US women

Study may lead to new therapies for patients suffering from Duchenne muscular dystrophy

New wireless implant can help measure oxygen levels deep inside the body

Self-assembling nanofibers can help limit damage caused by inflammatory diseases

Study identifies differences in biomarkers of inflammation between novel diabetes subgroups

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News